Literature DB >> 12654132

Reduced hepatic glycogen stores in patients with liver cirrhosis.

Lukas Krähenbühl1, Corinne Lang, Saskia Lüdes, Christian Seiler, Markus Schäfer, Arthur Zimmermann, Stephan Krähenbühl.   

Abstract

BACKGROUND: Patients with alcoholic liver cirrhosis have reduced hepatic glycogen stores but the mechanisms leading to this finding are not clear.
METHODS: We therefore determined the hepatic glycogen content in patients with alcoholic (n = 9) or biliary cirrhosis (n = 8), and in control patients undergoing liver surgery (n = 14). All patients were in the postabsorptive state. In addition, we performed a morphometric analysis of the livers, and measured activities and mRNA expression of several enzymes involved in glycogen metabolism. Cirrhotic and control patients were similar regarding age and body weight.
RESULTS: Cirrhotic patients had a reduced glycogen content per gram liver wet weight (17 +/- 11 versus 45 +/- 17 mg/g, P < 0.05), per milliliter hepatocytes (28 +/- 16 versus 52 +/- 21 mg/ml, P < 0.05) and per liver (28 +/- 17 versus 64 +/- 22 g, P < 0.05), the reduction being observed in both patients with alcoholic or biliary cirrhosis. Liver histology confirmed these findings and revealed that the decrease in liver glycogen in cirrhotic patients was not homogeneous across cirrhotic lobules. Activities of glycogen synthase and phosphorylase (total activity and active form) were not different between cirrhotic and control patients, whereas hepatic mRNA expression was decreased in cirrhotics by approximately 50%. The activity of glucokinase was decreased in cirrhotic as compared in control patients (0.06 +/- 0.30 versus 0.42 +/- 0.21 U/ml hepatocytes, P < 0.05), the reduction being observed in both patients with alcoholic or biliary cirrhosis.
CONCLUSIONS: We conclude that patients with alcoholic or biliary cirrhosis have decreased hepatic glycogen stores per volume of hepatocytes and per liver. Decreased activity of glucokinase may represent an important mechanism leading to this finding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654132     DOI: 10.1034/j.1600-0676.2003.00805.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

1.  The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.

Authors:  Xin M Wang; Lauren E Holz; Sumaiya Chowdhury; Shaun P Cordoba; Kathryn A Evans; Margaret G Gall; Ana Júlia Vieira de Ribeiro; Yuan Zhou Zheng; Miriam T Levy; Denise Mt Yu; Tsun-Wen Yao; Natasa Polak; Christopher J Jolly; Patrick Bertolino; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Immunol Cell Biol       Date:  2016-11-30       Impact factor: 5.126

2.  Magnetic resonance imaging of glycogen using its magnetic coupling with water.

Authors:  Yang Zhou; Peter C M van Zijl; Xiang Xu; Jiadi Xu; Yuguo Li; Lin Chen; Nirbhay N Yadav
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-30       Impact factor: 11.205

3.  Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Authors:  Douglas L Nguyen; Timothy Morgan
Journal:  Hepatol Int       Date:  2014-09-01       Impact factor: 6.047

4.  Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae.

Authors:  Deanna L Howarth; Chunyue Yin; Karen Yeh; Kirsten C Sadler
Journal:  Zebrafish       Date:  2013-05-22       Impact factor: 1.985

5.  Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver.

Authors:  Natalia N Bezborodkina; Sergey V Okovityi; Boris N Kudryavtsev
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

6.  Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis.

Authors:  Veronica Massey; Austin Parrish; Josepmaria Argemi; Montserrat Moreno; Aline Mello; Mar García-Rocha; Jose Altamirano; Gemma Odena; Laurent Dubuquoy; Alexandre Louvet; Carlos Martinez; Anna Adrover; Silvia Affò; Oriol Morales-Ibanez; Pau Sancho-Bru; Cristina Millán; Edilmar Alvarado-Tapias; Dalia Morales-Arraez; Juan Caballería; Jelena Mann; Sheng Cao; Zhaoli Sun; Vijay Shah; Andrew Cameron; Phillipe Mathurin; Natasha Snider; Càndid Villanueva; Timothy R Morgan; Joan Guinovart; Rajanikanth Vadigepalli; Ramon Bataller
Journal:  Gastroenterology       Date:  2020-12-10       Impact factor: 33.883

7.  Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.

Authors:  Komal Sodhi; Nitin Puri; Gaia Favero; Sarah Stevens; Charles Meadows; Nader G Abraham; Rita Rezzani; Hayden Ansinelli; Edward Lebovics; Joseph I Shapiro
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.

Authors:  Terry D Hinds; Komal Sodhi; Charles Meadows; Larisa Fedorova; Nitin Puri; Dong Hyun Kim; Stephen J Peterson; Joseph Shapiro; Nader G Abraham; Attallah Kappas
Journal:  Obesity (Silver Spring)       Date:  2013-12-02       Impact factor: 5.002

9.  Rapid Recapitulation of Nonalcoholic Steatohepatitis upon Loss of Host Cell Factor 1 Function in Mouse Hepatocytes

Authors:  Shilpi Minocha; Dominic Villeneuve; Viviane Praz; Catherine Moret; Maykel Lopes; Danièle Pinatel; Leonor Rib; Nicolas Guex; Winship Herr
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

10.  Genetic deletion of the circadian clock transcription factor BMAL1 and chronic alcohol consumption differentially alter hepatic glycogen in mice.

Authors:  Uduak S Udoh; Jennifer A Valcin; Telisha M Swain; Ashley N Filiano; Karen L Gamble; Martin E Young; Shannon M Bailey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-30       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.